Bod Australia achieved record total attributable sales of A$3.33m in Q2 FY21, a 52% increase on the previous quarter and a 144% rise on Q2 FY20.
Sales for the period were supported by a number of purchase orders from exclusive global partner Health and Happiness Group for the launch of CBD and hemp products in key markets including the Netherlands, France, Italy and the UK as well as increased prescription volumes of medicinal cannabis product MediCabilis.
Join the Cannabiz revolution
Want to stay ahead of the cannabis curve with the latest local and international news, analysis and intelligence and access to Australia's legal cannabis industry?
This article is included with our Premium subscription.
Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Sit amet consectetur adipiscing elit duis tristique sollicitudin nibh.
Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.